Drug Discovery. Drug Target Analysis. Drug Delivery. College of Pharmacy Genome to Drug Discovery Group

Size: px
Start display at page:

Download "Drug Discovery. Drug Target Analysis. Drug Delivery. College of Pharmacy Genome to Drug Discovery Group"

Transcription

1 College of Pharmacy Genome to Drug Discovery Group Drug Discovery Drug Delivery Drug Target Analysis Chemistry + Biology + Genetics = Advancing Human Health

2 College of Pharmacy Genome To Drug Discovery

3 The Bacterial Extracellular Proteome as Potential Therapeutic Target Intensity CFUs/mouse m/z wt T2S mutant Aleksandra Sikora

4 What makes Chlamydia Chlamydia? Chlamydia trachomatisinfected cells Vacuole bacteria Host nucleus Dan Rockey

5 Skin Wound Healing Healing of Chronic, diabetic, burn wounds is a major health concern Head and neck cancer Gitali Ganguli-Indra indrag@onid.orst.edu Cancer is a wound that does not heal Identify gene targets Identify factors to mobilize stem cells Validating targets Patient s biopsies & cancer cell lines C U R E Collaborators : A.Indra & M.Leid) New Drug Targets Identify pathways Diagnosis & Prevention 1. Patented Biomarker (Collaborator: A.Indra & M.Leid) 2.New anticancer drugs (Collaborator: T. Mahmud) C U R E

6 Taifo Mahmud Laboratory Department of Pharmaceutical Sciences Natural product discovery Drug Discovery and Development Biosynthetic engineering Chemical synthesis Infectious diseases and cancers Genome mining and metabolomics

7 OSU Natural Products as Probes to study Autophagy and Cell Death in cancer cells Jane Ishmael Pharmacology Mandelalide A discovered by Kerry McPhail in South Africa Coibamide A discovered by Kerry McPhail in Panama Coibamide A induces autophagy "self eating" in glioblastoma cells as a survival response but the cell still dies

8 Molecular CancerTherapeutics Siva Kolluri Molecular Therapeutics A new generation of drugs designed to interfere with a specific molecular target Our Focus: I. Dioxin Receptor from a mediator of toxic responses to an Anti-Cancer Target II. Conversion of Bcl-2 from a Protector to a Killer Protein New Molecular Targets For Breast Cancer

9 Novel inhibitors of the Receptor-tyrosine-kinase-like Orphan Receptor 2 (ROR2) enzyme for cancer treatment GENERAL RESEARCH FUND AWARD - URISC UNDERGRAD AWARD Wright et al. Oncogene 2009 Rasmussen et al. JBC 2013 CADD Artim et al. Biochem J 2012 A375 HCT116 RCC4 U2OS-3 tissue skin colon kidney bone Significance Innovation Interdisciplinarity Successful data drive publications and NHI grant submissions

10 Trans-kingdom network Andrey Morgun Assistant Professor College of Pharmacy (541) microbiome Host transcriptome Drivers of cervical cancer GERM FREE animals Usp

11 Cell Signaling in Organ Development and Disease Theresa Filtz, Ph.D. Pharmaceutical Sciences, College of Pharmacy 323 Pharmacy; ; To identify the cell signals that regulate cell differentiation through gene activation. To understand how enzymatic modifications of transcription factors change gene activation in development and disease. To reveal new drug targets that regulate gene activation in disease.

12 Pharmacy Practice Research What is pharmacy practice research? Examines how and why people access pharmacy services, the associated costs, and resulting patient outcomes My areas of interest include: Impact of clinical pharmacy services on quality metrics and patient outcomes Primary care Dynamics of federally qualified health centers (FQHC) Adriane Irwin

13 Nano-therapy for cancer treatment Drug solubilization Controlled release Drug targeting Combinatorial drug therapy Ease of administration Synergy/additive drug effects Imaging Radiotherapy Adam Alani

14 Multifunctional Nanomedicine Platforms for Cancer Treatment Chemotherapy Hyperthermia Photodynamic Therapy Gene Therapy Theranostic : Photodynamic Therapy and Image-Guided Drug Delivery Phthalocyanine Photodynamic Therapy Light Image-Guided Drug Delivery No light Tumor rs Oleh Taratula

15 Skin - Dr. Jekyll and Mr. Hyde NIAMS (R01) Leid and Indras Arup Indra eczema NIEHS (R01) Leung et. al, Journal of Clinical Investigation, Arup.indra@oregonstate.edu Melanoma :beast Eczema : itch Cause Cause Chambon and Indra Alani and Indra Cure Ctip2 ep-/- Ctip2 -/- Vehicle Drug Cure + +vehicle +Ack2 Ctip2 -/- Stevens and Indra XN TK inhibitor controls melanocyte survival Reduced Lymph Node invasion after targeted drug delivery

16 College of Pharmacy Genome To Drug Discovery

Developing Better Medicine

Developing Better Medicine SURF 2013 Marietta L. Harrison, PhD Director, Oncological Sciences Center in Discovery Park Professor, Medicinal Chemistry and Molecular Pharmacology How we do it today One size fits all Medicines aren

More information

Founded in 2016 to develop life-changing therapies against debilitating aggressive cancers that have limited treatment options

Founded in 2016 to develop life-changing therapies against debilitating aggressive cancers that have limited treatment options Founded in 2016 to develop life-changing therapies against debilitating aggressive cancers that have limited treatment options Integrated platform technology for discovery of novel molecular targets and

More information

Investigations of Pactamycin Biosynthesis Andrew Osborn

Investigations of Pactamycin Biosynthesis Andrew Osborn Investigations of Pactamycin Biosynthesis Andrew Osborn Research Mentors: Dr. Taifo Mahmud, Dr. Kerry McPhail A Bioresource Research Thesis Seminar Presentation Streptomyces pactum produces the antitumor

More information

Macmillan Publications

Macmillan Publications S1 S2 S3 S3 S3 S4 S5 S6 S7 S8 S8 S9 S10 S11 S11 S12 S13 S14 S15 S17 S18 S19 Bladder Cancer: Non-Invasive, Invasive and Advanced Bone Cancer: Primary, Secondary Colon Cancer, Anal Cancer, Rectal Cancer

More information

5 American Journal of Kidney Diseases Elsevier NEPHROLOGY Science Direct

5 American Journal of Kidney Diseases Elsevier NEPHROLOGY Science Direct 1 Acta Pharmacologica Sinica Publishing 2 Adolescent Psychiatry Psychiatry 3 American Heart Journal Elsevier CARDIOLOGY Science Direct 4 American Journal of Gastroenterology Publishing 5 American Journal

More information

Should novel molecular therapies replace old knowledge of clinical tumor biology?

Should novel molecular therapies replace old knowledge of clinical tumor biology? Should novel molecular therapies replace old knowledge of clinical tumor biology? Danai Daliani, M.D. Director, 1 st Oncology Clinic Euroclinic of Athens Cancer Treatments Localized disease Surgery XRT

More information

Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They?

Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Dubovenko Alexey Discovery Product Manager Sonia Novikova Solution Scientist September 2018 2 Non-Small Cell Lung Cancer

More information

Tuberous Sclerosis Complex Research Program

Tuberous Sclerosis Complex Research Program Tuberous Sclerosis Complex Research Program Strategic Plan INTRODUCTION The Congressionally Directed Medical Research Programs (CDMRP) represents a unique partnership among the U.S. Congress, the military,

More information

VeriStrat Poor Patients Show Encouraging Overall Survival and Progression Free Survival Signal; Confirmatory Phase 2 Study Planned by Year-End

VeriStrat Poor Patients Show Encouraging Overall Survival and Progression Free Survival Signal; Confirmatory Phase 2 Study Planned by Year-End AVEO and Biodesix Announce Exploratory Analysis of VeriStrat-Selected Patients with Non-Small Cell Lung Cancer in Phase 2 Study of Ficlatuzumab Presented at ESMO 2014 Congress VeriStrat Poor Patients Show

More information

Applications. in Oncology

Applications. in Oncology Kewal K. Jain Applications of Biotechnology in Oncology Applications of Biotechnology in Oncology Applications of Biotechnology in Oncology Kewal K. Jain, MD, FRACS, FFPM Jain PharmaBiotech, Basel, Switzerland

More information

Claudia Adams Barr Program in Innovative Cancer Research Dana-Farber Cancer Institute BARR PROGRAM IMPACT STATEMENTS

Claudia Adams Barr Program in Innovative Cancer Research Dana-Farber Cancer Institute BARR PROGRAM IMPACT STATEMENTS Claudia Adams Barr Program in Innovative Cancer Research Dana-Farber Cancer Institute BARR PROGRAM IMPACT STATEMENTS Brain Cancer New Treatment Opportunities - Discovery of new pathways in brain cancers

More information

UCI. Anti-Cancer Challenge Impact report. #weareanticancer

UCI. Anti-Cancer Challenge Impact report. #weareanticancer UCI Anti-Cancer Challenge 2017 Impact report #weareanticancer Your support of the UCI Anti-Cancer Challenge is planting the seeds from which UCI research will grow to improve cancer therapies! As Orange

More information

A View to the Future: The Development of Targeted Therapy for Melanoma. Michael Davies, M.D., Ph.D.

A View to the Future: The Development of Targeted Therapy for Melanoma. Michael Davies, M.D., Ph.D. A View to the Future: Science to Survivorship Symposium September 26, 2009 The Development of Targeted Therapy for Melanoma Michael Davies, M.D., Ph.D. Assistant Professor, Melanoma Medical Oncology How

More information

Diagnostic test Suggested website label Description Hospitals available

Diagnostic test Suggested website label Description Hospitals available Diagnostic test Suggested website label Description Hospitals available Abbott Molecular Inc, PATHVYSION HER-2 DNA Probe Kit (FISH) PathVysion kit A diagnostic tool used to determine whether a particular

More information

Lecture 1: Carcinogenesis

Lecture 1: Carcinogenesis Lecture 1: Carcinogenesis Anti-cancer (oncology agents): These are perhaps the most dangerous of drugs, other than the narcotic analgesics. This is due to their toxicities. Killing or inhibiting cancer

More information

Contents. Contributors...xi. Preface...xv. 1 Configurations, Structures and Morphologies of Cellulose... 1

Contents. Contributors...xi. Preface...xv. 1 Configurations, Structures and Morphologies of Cellulose... 1 Contents Contributors...xi Preface...xv 1 Configurations, Structures and Morphologies of Cellulose... 1 1.1 Introduction... 1 1.2 Structure... 2 1.2.1 Molecular Structure... 2 1.2.2 Hydrogen Bonding...

More information

BIT 120. Copy of Cancer/HIV Lecture

BIT 120. Copy of Cancer/HIV Lecture BIT 120 Copy of Cancer/HIV Lecture Cancer DEFINITION Any abnormal growth of cells that has malignant potential i.e.. Leukemia Uncontrolled mitosis in WBC Genetic disease caused by an accumulation of mutations

More information

CDx in oncology Prof. Christophe Le Tourneau, MD, PhD FEAM Geneva September 27, 2018

CDx in oncology Prof. Christophe Le Tourneau, MD, PhD FEAM Geneva September 27, 2018 CDx in oncology Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Head, Department of Drug Development and Innovation (D 3 i) INSERM U900 Research unit Versailles Saint-Quentin-en-Yvelines

More information

Section D: The Molecular Biology of Cancer

Section D: The Molecular Biology of Cancer CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Section D: The Molecular Biology of Cancer 1. Cancer results from genetic changes that affect the cell cycle 2. Oncogene proteins and faulty

More information

8/17/2011. FY 2010 President s Budget Request Total NIH Budget Authority $31.0 Billion

8/17/2011. FY 2010 President s Budget Request Total NIH Budget Authority $31.0 Billion NIH OD NCI NEI NHLBI NHGRI NIA NIAAA NIAID NIAMS NIBIB NICHD NIDCD NIDCR NIDDK NIDA NIEHS NIGMS NIMH NINDS NINR NLM CIT CSR FIC NCCAM NCMHD NCRR FY 2010 President s Budget Request Total NIH Budget Authority

More information

BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER

BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER SCIENTIFIC ADVISORY BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER Researchers from A*STAR s SBIC have discovered how changes in BCAA metabolism influence the development

More information

National Cancer Institute

National Cancer Institute National Cancer Institute Office of Cancer Complementary and Alternative Medicine ANNUAL REPORT ON COMPLEMENTARY AND ALTERNATIVE MEDICINE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes

More information

CELL BIOLOGY - CLUTCH CH CANCER.

CELL BIOLOGY - CLUTCH CH CANCER. !! www.clutchprep.com CONCEPT: OVERVIEW OF CANCER Cancer is a disease which is primarily caused from misregulated cell division, which form There are two types of tumors - Benign tumors remain confined

More information

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber jweber@dom.wustl.edu Oncogenes & Cancer DNA Tumor Viruses Simian Virus 40 p300 prb p53 Large T Antigen Human Adenovirus p300 E1A

More information

Phoenix Molecular Designs

Phoenix Molecular Designs Phoenix Molecular Designs DESIGNING PRECISE THERAPEUTICS TO REVOLUTIONIZE TREATMENT Our Team Dr. Sandra Dunn, Ph.D. Dr. Anna Stratford, Ph.D. Dr. Aarthi Jayanthan, Ph.D. Dr. Zaihui Zhang CEO, CSO UBC Professor

More information

EGFR: fundamenteel en klinisch

EGFR: fundamenteel en klinisch EGFR: fundamenteel en klinisch Guido Lammering MAASTRO Clinic Maastricht, NL What is EGFR?? The EGFR some facts 1186 amino acids 170 kda Expressed by all cells of epithelial origin Increased activation

More information

P U R D U E U N I V E R S I T Y C E N T E R F O R C A N C E R R E S E A R C H

P U R D U E U N I V E R S I T Y C E N T E R F O R C A N C E R R E S E A R C H A U G U S T 2 0 1 7 P U R D U E U N I V E R S I T Y C E N T E R F O R C A N C E R R E S E A R C H TIM'S TWIGS CANCER RESEARCH PROJECTS I N T R O D U C T I O N The fight against cancer begins in the laboratory

More information

Translational Clinical Research, the Key to Personalised Healthcare in Practice

Translational Clinical Research, the Key to Personalised Healthcare in Practice New Models of Collaborations with Academia to foster Translational Clinical Research, the Key to ersonalised Healthcare in ractice Exploratory Clinical Development World Europe Conference 2012 London,

More information

KLE UNIVERSITY. Annexure-IX I. FACULTY OF MEDICINE

KLE UNIVERSITY. Annexure-IX I. FACULTY OF MEDICINE Annexure-IX THRUST / PRIORITY AREAS OF RESEARCH IN HEALTH SCIENCES I. FACULTY OF MEDICINE Management Strategies in Immunology and Diagnostic Markers. Emerging Infections. Foetal Diagnosis and Foetal Medicine.

More information

Oncology Drug Development Using Molecular Pathology

Oncology Drug Development Using Molecular Pathology Oncology Drug Development Using Molecular Pathology Introduction PRESENTERS Lee Schacter, PhD, MD, FACP Executive Medical Director, Oncology Clinipace Worldwide Martha Bonino Director, Strategic Accounts

More information

Molecular Imaging and Cancer

Molecular Imaging and Cancer Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the U.S. Department of Health and Human Services, more than 512,000

More information

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis. Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)

More information

TTI-2341: A Novel Brain-Penetrant, Orally Available, Covalent EGFR Inhibitor for the Treatment of Brain Cancers

TTI-2341: A Novel Brain-Penetrant, Orally Available, Covalent EGFR Inhibitor for the Treatment of Brain Cancers TTI-2341: A Novel Brain-Penetrant, Orally Available, Covalent EGFR Inhibitor for the Treatment of Brain Cancers November 2017 2 EGFR is a Drug Target in Brain Cancer Epidermal growth factor receptor (EGFR)

More information

2017 Internship Directory: Summer Research Experience Program in Oncology- PA Student Applicants (6 pages)

2017 Internship Directory: Summer Research Experience Program in Oncology- PA Student Applicants (6 pages) Dhyan Chandra, PhD Pharmacology and Therapeutics /Dhyan-Chandra Role of Mitochondria in Cancer Prevention and Therapy The main focus of our research is to understand the molecular basis of therapy resistance

More information

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE 37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as

More information

Types of bladder cancer

Types of bladder cancer There are three main types of bladder cancer: Urothelial bladder cancer Squamous cell cancer Adenocarcinoma of the bladder There is more information about how we treat the different types of bladder cancer

More information

number Done by Corrected by Doctor Maha Shomaf

number Done by Corrected by Doctor Maha Shomaf number 19 Done by Waseem Abo-Obeida Corrected by Abdullah Zreiqat Doctor Maha Shomaf Carcinogenesis: the molecular basis of cancer. Non-lethal genetic damage lies at the heart of carcinogenesis and leads

More information

別紙 No. 掲載雑誌名 ISSN Impact Factor (2016) 1 Acs Nano Acta Biomaterialia Acta Crystallographica Section D-Structural

別紙 No. 掲載雑誌名 ISSN Impact Factor (2016) 1 Acs Nano Acta Biomaterialia Acta Crystallographica Section D-Structural 別紙 1 Acs Nano 1936-0851 13.942 2 Acta Biomaterialia 1742-7061 6.319 3 Acta Crystallographica Section D-Structural Biology 0907-4449 2.114 4 Acta Neuropathologica 0001-6322 12.213 5 Acta Ophthalmologica

More information

Fogarty Initiatives for Building Capacity in HIV/AIDS

Fogarty Initiatives for Building Capacity in HIV/AIDS Fogarty Initiatives for Building Capacity in HIV/AIDS April 13, 2010 Michael P. Johnson, M.D., M.P.H Deputy Director Fogarty International Center Global Health Transition in 21 st Century the unfinished

More information

First Phase 3 Results Presented for a PD-1 Immune Checkpoint Inhibitor

First Phase 3 Results Presented for a PD-1 Immune Checkpoint Inhibitor September 30, 2014 Positive Phase 3 Data for Opdivo (nivolumab) in Advanced Melanoma Patients Previously Treated with Yervoy @ (ipilimumab) Presented at the ESMO 2014 Congress First Phase 3 Results Presented

More information

2018 Internship Directory: High School Summer Research Experience Program in Cancer Science (10 pages)

2018 Internship Directory: High School Summer Research Experience Program in Cancer Science (10 pages) 2018 Internship Directory: High School Summer Mentor area(s) Internship Boyko Atanassov Dept. of Pharmacology and Therapeutics /Boyko-Atanassov cellular biology Defining the functions of Ubiquitin Specific

More information

Infinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results

Infinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results Infinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results Heat Shock Protein 90 Program Continues to Advance Toward Potential Registration Trial CAMBRIDGE, Mass.,

More information

The Role of Aryl Hydrocarbon Receptor in Mono-Substituted Isopropylated Triaryl Phosphate-Induced Cardiac Toxicity in Zebrafish

The Role of Aryl Hydrocarbon Receptor in Mono-Substituted Isopropylated Triaryl Phosphate-Induced Cardiac Toxicity in Zebrafish The Role of Aryl Hydrocarbon Receptor in Mono-Substituted Isopropylated Triaryl Phosphate-Induced Cardiac Toxicity in Zebrafish Cory V. Gerlach Mentor: Dr. Robert Tanguay Bioresource Research, University

More information

Impact of Prognostic Factors

Impact of Prognostic Factors Melanoma Prognostic Factors: where we started, where are we going? Impact of Prognostic Factors Staging Management Surgical intervention Adjuvant treatment Suraj Venna, MD Assistant Clinical Professor,

More information

Cancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage?

Cancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage? Questions about cancer What is cancer? Cancer Gil McVean, Department of Statistics, Oxford What causes unregulated cell growth? What regulates cell growth? What causes DNA damage? What are the steps in

More information

How to address tumour heterogeneity in next generation oncology trials

How to address tumour heterogeneity in next generation oncology trials How to address tumour heterogeneity in next generation oncology trials Cihangir YANDIM, PhD Research Associate in Cancer Therapeutics and Clinical Sciences Dr. Cihangir Yandim - CTIP 2016, Hamburg 1 Founded

More information

Fitting the Treatment to the Patient Roche Personalized Healthcare. February 24, 2012

Fitting the Treatment to the Patient Roche Personalized Healthcare. February 24, 2012 Fitting the Treatment to the Patient Roche Personalized Healthcare February 24, 2012 Roche Group Pharmaceuticals Roche Pharma Genentech Chugai Applied Science Molecular Professional Tissue Diabetes Care

More information

CANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients

CANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients CANCER MEDICINES IN DEVELOPMENT 2018 REPORT JUST THE FACTS MORE THAN 1.7 M ESTIMATED NEW CASES OF CANCER IN 2018 IN THE UNITED STATES MORE THAN 609,000 U.S. CANCER DEATHS ARE EXPECTED IN 2018 SINCE PEAKING

More information

2(iii): Prognostic biomarkers 2(iv): Biomarkers based on Cancer Types

2(iii): Prognostic biomarkers 2(iv): Biomarkers based on Cancer Types 15 August 2011 (Monday) Track 2(iii) 2(iv) 2(iii): Prognostic biomarkers 2(iv): Biomarkers based on Cancer Types Session Chair Dr. Jimmy Efird Brody School of Medicine, USA Session Co-Chair Dr. Shyamal

More information

Revolutionizing the Treatment of Cancer

Revolutionizing the Treatment of Cancer Revolutionizing the Treatment of Cancer June 2014 Safe Harbor Statement The statements that follow (including projections and business trends) are forward looking statements. Rexahn's actual results may

More information

Quantitative LC/LC/MS/MS of Mixed Proteomes Application to Studies of Human Infectious Disease and Bacterial Endosymbionts

Quantitative LC/LC/MS/MS of Mixed Proteomes Application to Studies of Human Infectious Disease and Bacterial Endosymbionts Quantitative LC/LC/MS/MS of Mixed Proteomes Application to Studies of Human Infectious Disease and Bacterial Endosymbionts J. Will Thompson 1, Laura G. Dubois 1, Hector A. Saka 2, Yi-Shan Chen 2, Yadunanda

More information

Cancer and Gene Alterations - 1

Cancer and Gene Alterations - 1 Cancer and Gene Alterations - 1 Cancer and Gene Alteration As we know, cancer is a disease of unregulated cell growth. Although we looked at some of the features of cancer when we discussed mitosis checkpoints,

More information

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives 2008 Oncology Pharmacy Preparatory Review Course Learning Objectives Session 1 Symptom Management, Part I, II & III Teresa A. Mays, Pharm D., BCOP Director, Investigational Drug Department San Antonio,

More information

Nanotechnology applications in medical diagnosis, imaging, and therapy

Nanotechnology applications in medical diagnosis, imaging, and therapy Engineering Conferences International ECI Digital Archives Nanotechnology in Medicine: From Molecules to Humans Proceedings 7-4-2016 Nanotechnology applications in medical diagnosis, imaging, and therapy

More information

Effector T Cells and

Effector T Cells and 1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New

More information

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland AWARD NUMBER: W81XWH-13-1-0203 TITLE: Targeting almitoyl cyltransferases in NRAS- elanoma PRINCIPAL INVESTIGATOR: Xu Wu, Ph.D. CONTRACTING ORGANIZATION: Massachusetts General Hospital, Boston, MA 02114

More information

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM BOARD OF PHARMACY SPECIALTIES ONCOLOGY PHARMACY SPECIALIST CERTIFICATION CONTENT OUTLINE/CLASSIFICATION SYSTEM FINALIZED SEPTEMBER 2016/FOR USE ON FALL 2017 EXAMINATION AND FORWARD UNDERSTANDING THE CONTENT

More information

SER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017

SER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017 SER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017 Leading the Microbiome Revolution Forward Looking Statements Some of the statements in this presentation

More information

Genentech Research & Early Development

Genentech Research & Early Development Genentech Research & Early Development Founders Research Centers 1 & 2 Founders Research Centers 1 & 2 Andrew Chan, M.D., Ph.D. Senior Vice President, Research Biology September 2017 gred focus areas Discovering

More information

DOWNLOAD OR READ : UPDATE ON BIOMARKERS IN ASTHMA AN ISSUE OF IMMUNOLOGY AND ALLERGY CLINICS PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : UPDATE ON BIOMARKERS IN ASTHMA AN ISSUE OF IMMUNOLOGY AND ALLERGY CLINICS PDF EBOOK EPUB MOBI DOWNLOAD OR READ : UPDATE ON BIOMARKERS IN ASTHMA AN ISSUE OF IMMUNOLOGY AND ALLERGY CLINICS PDF EBOOK EPUB MOBI Page 1 Page 2 update on biomarkers in asthma an issue of immunology and allergy clinics

More information

Pancreatic Adenocarcinoma: What`s hot

Pancreatic Adenocarcinoma: What`s hot Pancreatic Adenocarcinoma: What`s hot Eva Karamitopoulou-Diamantis Institute of Pathology University of Bern 11.09.2018, 30th ECP, Bilbao Pancreatic Cancer and the Microbiome The Pancreatic Cancer Microbiome

More information

Skin Cancer - Non-Melanoma

Skin Cancer - Non-Melanoma Skin Cancer - Non-Melanoma Introduction Each year, millions of people find out that they have skin cancer. Skin cancer is almost 100% curable if found early and treated right away. It is possible to prevent

More information

Targeted Medicine and Molecular Therapeutics. Angus McIntyre, M.D. Medical Oncologist, Addison Gilbert Hospital and Beverly Hospital October 6, 2009

Targeted Medicine and Molecular Therapeutics. Angus McIntyre, M.D. Medical Oncologist, Addison Gilbert Hospital and Beverly Hospital October 6, 2009 Targeted Medicine and Molecular Therapeutics Angus McIntyre, M.D. Medical Oncologist, Addison Gilbert Hospital and Beverly Hospital October 6, 2009 Approaches to Cancer Prevention Screening and early diagnosis

More information

Integrative Medicine: A Foundation for Prospective Health Care

Integrative Medicine: A Foundation for Prospective Health Care Integrative Medicine: A Foundation for Prospective Health Care Distinguished Lectures in the Science of Complementary and Alternative Medicine National Institutes of Health April 22, 2005 c. 3,500 BCE

More information

TREAT U is a spin-off from the University of Coimbra, founded in January 2010, and headquartered in Coimbra, Portugal.

TREAT U is a spin-off from the University of Coimbra, founded in January 2010, and headquartered in Coimbra, Portugal. TREAT U is a spin-off from the University of Coimbra, founded in January 2010, and headquartered in Coimbra, Portugal. MISSION & VISION Our mission is to develop more effective strategies and safer products

More information

Clinical Policy: Nivolumab (Opdivo) Reference Number: CP.PHAR.121

Clinical Policy: Nivolumab (Opdivo) Reference Number: CP.PHAR.121 Clinical Policy: (Opdivo) Reference Number: CP.PHAR.121 Effective Date: 07/15 Last Review Date: 04/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory

More information

SINGAPORE SCIENTISTS DISCOVER NEW PATHWAYS LEADING TO CANCER PROGRESSION

SINGAPORE SCIENTISTS DISCOVER NEW PATHWAYS LEADING TO CANCER PROGRESSION MEDIA RELEASE FOR IMMEDIATE RELEASE 18 JULY 2016 SINGAPORE SCIENTISTS DISCOVER NEW PATHWAYS LEADING TO CANCER PROGRESSION SINGAPORE Scientists from A*STAR s Genome Institute of Singapore (GIS) and the

More information

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research Action to Cure Kidney Cancer 2016 Campaign to Fund Kidney Cancer Research Kidney Cancer Facts 9 th most common cancer in the U.S. Until recently, 3 rd highest rate of increasing incidence of all cancers

More information

Corporate Presentation October 2018 Nasdaq: ADXS

Corporate Presentation October 2018 Nasdaq: ADXS Innovations in Immuno-Oncology Corporate Presentation October 2018 Nasdaq: ADXS Forward-Looking Statements This presentation contains forward-looking statements, including, but not limited to, statements

More information

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX Contents Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX 1 General Aspects of Signal Transduction and Cancer Therapy 1 1.1 General Principles of Signal Transduction

More information

Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia (CLL) Page 1 of 10 PATIENT EDUCATION Chronic Lymphocytic Leukemia (CLL) Introduction Chronic lymphocytic leukemia (CLL) is a type of cancer of the lymphocytes (a kind of white blood cell). It is also referred

More information

Therapeutic Programming of Synthetic Biotic Medicines

Therapeutic Programming of Synthetic Biotic Medicines Therapeutic Programming of Synthetic Biotic Medicines Synthetic Biotic TM medicines to perform and deliver critical therapeutic functions to treat diseases throughout the body An Engineered E. coli Nissle

More information

Lymphoma is a cancer that develops in the white blood cells (lymphocytes) of the lymphatic system, which is part of the body's immune system.

Lymphoma is a cancer that develops in the white blood cells (lymphocytes) of the lymphatic system, which is part of the body's immune system. Scan for mobile link. Lymphoma Lymphoma is a cancer that develops in the white blood cells of the lymphatic system. Symptoms may include enlarged lymph nodes, unexplained weight loss, fatigue, night sweats

More information

China Medical Technologies, Inc.

China Medical Technologies, Inc. China Medical Technologies, Inc. China Medical Technologies, Inc. (CMT) is a high-tech enterprise, trading on Nasdaq with the ticker CMED. We currently conduct our operations principally through our wholly-owned

More information

C A N C É R O P Ô L E L Y O N A U V E R G N E R H Ô N E - A L P E S

C A N C É R O P Ô L E L Y O N A U V E R G N E R H Ô N E - A L P E S Cancer Research Cluster to Facilitate and Structure Oncology Research C A N C É R O P Ô L E L Y O N A U V E R G N E R H Ô N E - A L P E S s P E E D I N G U P P R O G R E S S CANCÉROPÔLE LYON AUVERGNE RHÔNE-ALPES

More information

Kidney Cancer Diagnostic Kit

Kidney Cancer Diagnostic Kit Kidney Cancer Diagnostic Kit Multiplex Human Renal Cell carcinoma Biomarker Test Kit ELISA kit for Human Renal Cell Carcinoma A simple antibody-based blood test designed to detect kidney cancer a Non-invasive,

More information

Astrid Pujari, MD

Astrid Pujari, MD Astrid Pujari, MD www.pujaricenter.com Not just germs: tumor cells too! White blood cells Natural killer cells T cells Organs Spleen, thymus, tonsils Bone marrow Lymph nodes Lymphatic system Roads that

More information

Real time connection of Mass Spectrometry with Medicine and Surgery

Real time connection of Mass Spectrometry with Medicine and Surgery GBS 724 March 18, 2016 Real time connection of Mass Spectrometry with Medicine and Surgery Stephen Barnes, PhD Professor of Pharmacology & Toxicology Director, Targeted Metabolomics and Proteomics Laboratory

More information

Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells. Matthew G. Vander Heiden, et al. Science 2010

Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells. Matthew G. Vander Heiden, et al. Science 2010 Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells Matthew G. Vander Heiden, et al. Science 2010 Introduction The Warburg Effect Cancer cells metabolize glucose differently Primarily

More information

Liquid Biopsy Applications on the Idylla Fully Integrated Sample-to-Result MDx System

Liquid Biopsy Applications on the Idylla Fully Integrated Sample-to-Result MDx System Liquid Biopsy Applications on the Idylla Fully Integrated Sample-to-Result MDx System Erwin Sablon, Head of R&D, Biocartis NV World CDx, Boston, September 10 th 2015 0 About Biocartis Innovative molecular

More information

ISOGENIC CELL LINES. ATCC No. Designation Mutation Parental Cell Line Disease Cancer Model

ISOGENIC CELL LINES. ATCC No. Designation Mutation Parental Cell Line Disease Cancer Model THE ESSENTILS OF LIFE SCIENCE RESERCH GLOLLY DELIVERED ISOGENIC CELL LINES TCC CRISPR/CS9 GENE-EDITED ISOGENIC CELL LINES Clinically relevant cell models are critical for studies of molecular and cellular

More information

ISPOR 4 th Asia Pacific Conference IP2 Gilberto de Lima Lopes

ISPOR 4 th Asia Pacific Conference IP2 Gilberto de Lima Lopes Health Economic Considerations for Personalized Medicine in Asia: Using Genomic Profiling to Guide Treatment Decisions in Early Breast Cancer Gilberto de Lima Lopes, Jr., M.D., M.B.A Assistant Director

More information

The use of molecular nutrition and nutrigenomics research to understand metabolic plasticity and health

The use of molecular nutrition and nutrigenomics research to understand metabolic plasticity and health The use of molecular nutrition and nutrigenomics research to understand metabolic plasticity and health Michael Müller Professor of Nutrigenomics & Systems Nutrition @nutrigenomics You are what you eat,

More information

Genome Editing Research for Translational Toxicology Solutions

Genome Editing Research for Translational Toxicology Solutions Genome Editing Research for Translational Toxicology Solutions REBECCA FRY, PH.D. Carol Remmer Angle Distinguished Professor and Associate Chair Director, UNC Superfund Research Program Director, Graduate

More information

Dr C K Kwan. Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK

Dr C K Kwan. Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK HA Convention 2013 Dr C K Kwan MBChB, FRCR, FHKCR, FHKAM, MPM, CPI, MAppMgt(Hlth) Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK To personalize cancer

More information

Lesson 19 Study Guide: Medical Biotechnology Cancer Treatment

Lesson 19 Study Guide: Medical Biotechnology Cancer Treatment URI CMB 190 Issues in Biotechnology Lesson 19 Study Guide: Medical Biotechnology Cancer Treatment 11. There have been genes that have been identified to be associated with certain types of cancer. Microarrays

More information

Translating Duke Health. Accelerating discovery and its translation

Translating Duke Health. Accelerating discovery and its translation Translating Duke Health Accelerating discovery and its translation Translating Duke Health Biomedical discovery is accelerating innovative and revolutionary advancements in our understanding of human biology,

More information

CRIPTO-1 A POSSIBLE NEW BIOMARKER IN GLIOBLASTOMA MULTIFORME PIA OLESEN, MD, PHD STUDENT

CRIPTO-1 A POSSIBLE NEW BIOMARKER IN GLIOBLASTOMA MULTIFORME PIA OLESEN, MD, PHD STUDENT CRIPTO-1 A POSSIBLE NEW BIOMARKER IN GLIOBLASTOMA MULTIFORME PIA OLESEN, MD, PHD STUDENT Glioblastoma WHO Grade IV Glioma Heterogenic Undiffenrentiated phenotype 50% of all Gliomas Around 600 patients

More information

Supplementary Tables. Supplementary Figures

Supplementary Tables. Supplementary Figures Supplementary Files for Zehir, Benayed et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients Supplementary Tables Supplementary Table 1: Sample

More information

PROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund

PROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund PROGRESS UPDATE Evan T. Mandeville DIPG Research Fund December 2018 EXECUTIVE SUMMARY As a top-ranked pediatric cancer center, Dana-Farber Cancer Institute combines first-rate patient care with groundbreaking

More information

Chapter 1: Curcumin is excellent compound for various medicinal usages

Chapter 1: Curcumin is excellent compound for various medicinal usages Super-Curcumin Story Chapter 1: Curcumin is excellent compound for various medicinal usages Chapter 2: Discovery of Super-Curcumin analog Chapter 3: Anti-tumor activities of Super-Curcumin analog Chapter

More information

Government Bioscience Grant (GBG) Report April 2015

Government Bioscience Grant (GBG) Report April 2015 www.g2gconsulting.com www.michbio.org Government Bioscience Grant (GBG) Report April 2015 Title (Agency) Opp. Number Description Deadlin e Funding Level Eligibility Link KIDNEY 1 Pilot and Feasibility

More information

MicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL

MicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL MicroRNA expression profiling and functional analysis in prostate cancer Marco Folini s.c. Ricerca Traslazionale DOSL What are micrornas? For almost three decades, the alteration of protein-coding genes

More information

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Cancer is a group of more than 100 different diseases that are characterized by uncontrolled cellular growth,

More information

O-Glycosylation of Transcription Factor BCL11b: Truth or Myth?

O-Glycosylation of Transcription Factor BCL11b: Truth or Myth? O-Glycosylation of Transcription Factor BCL11b: Truth or Myth? Elizabeth Pendergrass Dr. Theresa Filtz Dept Of Pharmaceutical Sciences College Of Pharmacy Oregon State University T-cell Leukemia T-cell

More information

University of Bristol Cancer Research Fund Report

University of Bristol Cancer Research Fund Report University of Bristol Cancer Research Fund 2014 Report University of Bristol Cancer Research Fund 2014 Report Introduction This report details the outcomes of the research projects funded from the 2013

More information

Genome of Hepatitis B Virus. VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department

Genome of Hepatitis B Virus. VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department Genome of Hepatitis B Virus VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department Proto Oncogen and Oncogen Oncogen Proteins that possess the ability to cause

More information

2016 CANCER PROGRAM REPORT. Bay Medical Sacred Heart Health System 615 North Bonita Avenue Panama City, FL

2016 CANCER PROGRAM REPORT. Bay Medical Sacred Heart Health System 615 North Bonita Avenue Panama City, FL 2016 CANCER PROGRAM REPORT Bay Medical Sacred Heart Health System 615 North Bonita Avenue Panama City, FL 32401 850.769.1511 www.baymedical.org 2016 Cancer Program Report Bay Medical Sacred Heart provides

More information

What are Clinical Trials

What are Clinical Trials What are Clinical Trials Clinical Trials are systematic studies designed to discover and verify the effects and/or adverse reactions of drugs (pharmacodynamics) and the absorption, distribution, metabolism

More information

Understanding the mechanisms of asbestos related diseases

Understanding the mechanisms of asbestos related diseases University of Hawai i Cancer Center Understanding the mechanisms of asbestos related diseases Haining Yang, PhD Professor University of Hawai i Cancer Center Marker of exposure: Bilateral pleural plaques

More information